click below
click below
Normal Size Small Size show me how
osteoporosis
ch 19, therapeutic agents for the musculoskeletal system, pharm tech
| Question | Answer |
|---|---|
| osteoporosis | systemic skeletal disease characterized by low bone mass and bone tissue deterioration which leads to fragility and bone fracture |
| kyphosis | bent over, stooped posture from vertebral fracture |
| drug classes to treat osteoporosis | bisphosphonates, calcium supplements, parathyroid hormone analog, monoclonal antibody, misc agents |
| bisphosphonates | treatment of choice for osteoporosis (inhibit resorption of calcium from bone) |
| Fosamax | alendronate *bisphosphonates; PO once weekly |
| Boniva | ibandronate *bisphosphonates; injected every 3 months |
| Actonel | risedronate *bisphosphonates; PO once weekly |
| Reclast | zoledronic acid *bisphosphonates; injected once yearly |
| Parathyroid Hormone Analogue | Forteo / teriparatide *daily inj |
| Monoclonal antibody | Prolia / denosumab; inhibits osteoclast activation |
| supplements | to provide adequate calcium intake |
| Citracal + D | calcium and vitamin D *supplement |
| Caltrate, Os-Cal, Tums | calcium carbonate *supplement |
| Misc agents | Miacalcin / calcitonin-salmon *calcitonin nasal spray; *ususally reserved for those unable to take bisphosphonates |
| Selective Estrogen Receptor Modulator (SERM) | Evista / raloxifene *ususally reserved for those unable to take bisphosphonates |